Literature DB >> 17631917

Microglia produce and hydrolyze palmitoylethanolamide.

Giulio G Muccioli1, Nephi Stella.   

Abstract

Microglial cell activation and migration play an important role in neuroinflammation propagation. While it is known that the lipid transmitter palmitoylethanolamide (PEA) regulates microglial migration by interacting with a cannabinoid-like receptor, the production and inactivation of this lipid by microglia has never been addressed directly. Here we show that the mouse microglial cell line BV-2 produces and hydrolyzes PEA. The carbamate compound URB602 inhibits PEA hydrolysis in BV-2 cell homogenates and increases PEA levels in intact cells, whereas the FAAH inhibitor URB597 and serine-hydrolase inhibitor MAFP do not affect PEA levels in intact cells. This unique pharmacological profile of inhibitors on PEA hydrolysis suggests the involvement of a previously undescribed enzyme that degrades PEA. This enzyme expressed by microglia constitutes a promising target for controlling the propagation of neuroinflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631917      PMCID: PMC2254322          DOI: 10.1016/j.neuropharm.2007.05.015

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  39 in total

1.  Modulation of anxiety through blockade of anandamide hydrolysis.

Authors:  Satish Kathuria; Silvana Gaetani; Darren Fegley; Fernando Valiño; Andrea Duranti; Andrea Tontini; Marco Mor; Giorgio Tarzia; Giovanna La Rana; Antonio Calignano; Arcangela Giustino; Maria Tattoli; Maura Palmery; Vincenzo Cuomo; Daniele Piomelli
Journal:  Nat Med       Date:  2002-12-02       Impact factor: 53.440

2.  Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.

Authors:  Di Zhang; Anita Saraf; Teodozyi Kolasa; Pramila Bhatia; Guo Zhu Zheng; Meena Patel; Greg S Lannoye; Paul Richardson; Andrew Stewart; John C Rogers; Jorge D Brioni; Carol S Surowy
Journal:  Neuropharmacology       Date:  2007-01-09       Impact factor: 5.250

3.  Astrocytes in culture produce anandamide and other acylethanolamides.

Authors:  Lisa Walter; Allyn Franklin; Anke Witting; Thomas Moller; Nephi Stella
Journal:  J Biol Chem       Date:  2002-03-26       Impact factor: 5.157

4.  An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors.

Authors:  N Ueda; K Yamanaka; Y Terasawa; S Yamamoto
Journal:  FEBS Lett       Date:  1999-07-09       Impact factor: 4.124

5.  Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.

Authors:  K O Jonsson; S Vandevoorde; D M Lambert; G Tiger; C J Fowler
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

6.  Receptor-dependent formation of endogenous cannabinoids in cortical neurons.

Authors:  N Stella; D Piomelli
Journal:  Eur J Pharmacol       Date:  2001-08-17       Impact factor: 4.432

7.  Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors.

Authors:  D M Lambert; F G DiPaolo; P Sonveaux; M Kanyonyo; S J Govaerts; E Hermans; J Bueb; N M Delzenne; E J Tschirhart
Journal:  Biochim Biophys Acta       Date:  1999-09-22

8.  Fatty acid amide hydrolase substrate specificity.

Authors:  D L Boger; R A Fecik; J E Patterson; H Miyauchi; M P Patricelli; B F Cravatt
Journal:  Bioorg Med Chem Lett       Date:  2000-12-04       Impact factor: 2.823

9.  The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain.

Authors:  S I Jaggar; F S Hasnie; S Sellaturay; A S Rice
Journal:  Pain       Date:  1998-05       Impact factor: 6.961

10.  The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

Authors:  Jesse Lo Verme; Jin Fu; Giuseppe Astarita; Giovanna La Rana; Roberto Russo; Antonio Calignano; Daniele Piomelli
Journal:  Mol Pharmacol       Date:  2004-10-01       Impact factor: 4.436

View more
  36 in total

Review 1.  Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.

Authors:  Stephen D Skaper; Laura Facci; Mariella Fusco; Maria Federica Della Valle; Morena Zusso; Barbara Costa; Pietro Giusti
Journal:  Inflammopharmacology       Date:  2013-11-01       Impact factor: 4.473

2.  Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1.

Authors:  Neta Rimmerman; Heather B Bradshaw; Ewa Kozela; Rivka Levy; Ana Juknat; Zvi Vogel
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 3.  Role of Microglial Activation in the Pathophysiology of Bacterial Meningitis.

Authors:  Tatiana Barichello; Jaqueline S Generoso; Lutiana R Simões; Jessica A Goularte; Fabricia Petronilho; Priyanka Saigal; Marwa Badawy; João Quevedo
Journal:  Mol Neurobiol       Date:  2015-03-07       Impact factor: 5.590

4.  Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists.

Authors:  Talia N Lerner; Eric A Horne; Nephi Stella; Anatol C Kreitzer
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

Review 5.  The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.

Authors:  Stefania Petrosino; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2016-09-29       Impact factor: 8.739

6.  Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α.

Authors:  Marco Koch; Susanne Kreutz; Charlotte Böttger; Alexander Benz; Erik Maronde; Chalid Ghadban; Horst-Werner Korf; Faramarz Dehghani
Journal:  Neurotox Res       Date:  2010-03-11       Impact factor: 3.911

7.  Micronized palmitoylethanolamide reduces joint pain and glial cell activation.

Authors:  Maria Lavinia Bartolucci; Ida Marini; Francesco Bortolotti; Daniela Impellizzeri; Rosanna Di Paola; Giuseppe Bruschetta; Rosalia Crupi; Marco Portelli; Angela Militi; Giacomo Oteri; Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Inflamm Res       Date:  2018-08-18       Impact factor: 4.575

8.  Genetic manipulation of palmitoylethanolamide production and inactivation in Saccharomyces cerevisiae.

Authors:  Giulio G Muccioli; Angela Sia; Paul J Muchowski; Nephi Stella
Journal:  PLoS One       Date:  2009-06-16       Impact factor: 3.240

9.  Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain.

Authors:  Leonardo Guasti; Denise Richardson; Maulik Jhaveri; Khalil Eldeeb; David Barrett; Maurice R Elphick; Stephen P H Alexander; David Kendall; Gregory J Michael; Victoria Chapman
Journal:  Mol Pain       Date:  2009-07-01       Impact factor: 3.395

Review 10.  Dynamic regulation of the endocannabinoid system: implications for analgesia.

Authors:  Devi Rani Sagar; A Gemma Gaw; Bright N Okine; Stephen G Woodhams; Amy Wong; David A Kendall; Victoria Chapman
Journal:  Mol Pain       Date:  2009-10-08       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.